Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Examining unmet needs in infectious disease.

Noel J C Snell1

  • 1National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse Street, SW3 6LY, London, UK. noel.snell@astrazeneca.com

Drug Discovery Today
|January 28, 2003
PubMed
Summary

Over 30 new infectious disease agents have emerged in 30 years, alongside resurgent diseases like tuberculosis. This review explores unmet therapeutic needs and strategies for infectious disease control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discontinued drug projects in the respiratory therapeutic area during 2012.

Expert opinion on investigational drugs·2014
Same author

Tuberculosis susceptibility--implications for drug development and therapy.

Expert opinion on pharmacotherapy·2003
See all related articles

Area of Science:

  • * Infectious disease epidemiology and emergence.
  • * Novel and re-emerging infectious diseases.
  • * Antimicrobial resistance and public health.

Background:

  • * Identification of over 30 new infectious disease agents in the last 30 years.
  • * Emergence of novel life-threatening diseases including AIDS, Ebola, hantavirus pulmonary syndrome, and Nipah virus encephalitis.
  • * Resurgence of established infectious diseases like tuberculosis due to complacency, travel, social factors, and drug resistance.

Purpose of the Study:

  • * To review key unmet needs in the therapeutic area of infectious diseases.
  • * To discuss strategies for addressing these unmet needs.
  • * To highlight the evolving landscape of infectious disease threats.

Main Methods:

  • * Review of scientific literature on emerging and re-emerging infectious diseases.
  • * Analysis of factors contributing to disease resurgence.
  • * Identification of therapeutic gaps and potential strategies.

Main Results:

  • * Significant increase in novel infectious disease agents.
  • * Growing challenge of antimicrobial resistance.
  • * Need for innovative therapeutic approaches.

Conclusions:

  • * Urgent need for new treatments and preventative strategies for infectious diseases.
  • * Addressing complacency and improving global health infrastructure are crucial.
  • * Continued research and development are essential to combat evolving infectious disease threats.

Related Experiment Videos